BioSpace News Archive

This partnership with the AP-HM could lead to a world first and opens up important applications in the field of regenerative medicine.

Delivering an efficient, seamless process for clinical labels from protocol to print

Using artificial intelligence and machine learning, the collaboration will focus on delivering new technology to help enable faster delivery of medical therapies to the biotech and pharma industries

TreeFrog Therapeutics, a pure player in iPSC-derived cell therapies, announces the appointment of 2 senior executives and 2 independent board members.

Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, and the renowned University of Utah have published scientific investigations that provide initial evidence for further significant benefits of the innovative Marinosolv® platform in the field of corneal eye diseases.

Linshom announced U.S. Food and Drug Administration 510 clearance of the company’s first product, a small, non-invasive respiratory monitor that addresses the growing need for continuous respiratory monitoring for patients susceptible to respiratory depression and compromise.

More than five million women suffer from symptoms of uterine fibroids, with more than half of them estimated to have received inadequate treatment. However, new data released by Myovant shows that concerns of inadequate treatment could soon change.

“The FDA filing acceptance for Libervant is an important milestone in our mission to provide epilepsy patients with a broader array of treatment options, that represent major contributions to patient care,” said Keith J. Kendall, Aquestive’s chief executive officer.

KSQ announced it had identified and validated a novel target, CT-1, that it plans to develop an engineered tumor-infiltrating lymphocyte (eTIL) therapy for.

Establishing rapport with someone you’ve just met who also may hold your future in their hands is not easy. Continue reading to discover how to establish rapport with your interviewer.